Cancer biomarkers (CB) are biomolecules produced either by the tumor cells or by other cells of the body in response to the tumor. Most cancer biomarkers in clinical use are not suitable for population screening or for early diagnosis, and the use of prostate-specific antigen for prostate cancer screening is still controversial.